CEG — Constellation Energy Corporation

As of 2026-08-27, sell-side sentiment is solidly constructive: 15 Buy ratings, 6 Holds, zero Sells, consensus target $354.50 and recent average target $350.09. Q2 2026 adjusted EPS of $2.55 beat Street estimates, and management raised full-year 2026 adjusted EPS guidance to $11.50-$12.50. The offset is that price targets have been trimmed from the stock's $412.70 peak and price is still below the 200-day SMA, so the market is bullish on the thesis but not aggressively chasing the stock.

The trend data is distorted by the Calpine acquisition: reported revenue jumped from $5.46B in Q4 2025 to $11.12B in Q1 2026, then settled to $7.51B in Q2 2026; stockholders' equity jumped from $14.5B to $33.5B over the same period. TTM revenue through Q2 2026 is roughly $31.3B. GAAP EPS has been lumpy — Q1 2026 $4.49, Q2 2026 $1.45 — but adjusted operating EPS of $2.55 in Q2 2026 beat consensus and the full-year guidance was raised. GAAP operating margin compressed to 7.7% in Q2 2026 from 15.6% a year earlier, reflecting seasonality, acquisition-related costs, and integration noise more than structural deterioration. On an adjusted-earnings basis, the trajectory is inflecting upward.

At $282.41, CEG trades at about 27.4x trailing GAAP EPS and roughly 23.4x forward EPS using the $12.00 midpoint of FY2026 guidance or the $12.045 consensus estimate. Price-to-sales is 3.24x versus the 5-year average of 2.14x, and the stated trailing PEG is 3.76, although forward PEG is closer to ~1.0 using 2026 EPS growth to ~$12. TTM free cash flow is only about $0.3B against a $101B market cap, so on cash and sales multiples the stock is rich. On forward adjusted earnings, it is more reasonable but still not cheap.

The stock has already de-rated from about 34x forward earnings at the $412.70 high to roughly 23x forward earnings at $282.41. That means the current price is no longer pricing in flawless execution; it is pricing in solid delivery of the AI/PJM/nuclear thesis. If CEG hits the upper half of the $11.50-$12.50 guidance and continues signing long-term nuclear PPAs, a re-rate toward the $350 average target is plausible. If guidance slips or FCF stays negative, the multiple could compress toward 18-20x, implying $216-$240. This is an execution-dependent stock, not a deep-value situation.

As of 2026-08-27, RSI is 60.4, price is +3.3% above the 20-day SMA (~$273) and +6.7% above the 50-day SMA (~$265), but still -5.3% below the 200-day SMA (~$298). That is a rebound within a longer-term downtrend rather than a confirmed new uptrend. The key technical level is roughly $298; reclaiming the 200-day would turn the chart positive. Failure there could lead to another test of $265-$273. RSI has room before overbought, so momentum can continue, but the entry timing is not ideal until the 200-day is reclaimed or a lower-risk pullback appears.

• AI/data-center baseload demand: hyperscalers need 24/7 carbon-free power, making nuclear PPAs strategically scarce.
• PJM capacity auction prices: structurally higher clearing prices directly boost merchant revenue for CEG's fleet.
• Nuclear Production Tax Credits: federal support for existing nuclear generation underpins cash-flow visibility.
• Interest rates: higher-for-longer rates pressure capital-intensive, high-multiple clean-energy equities and raise Calpine integration financing costs.
• Natural gas prices: lower gas can pressure power prices and spark spreads for the acquired Calpine gas fleet, while high gas makes nuclear more valuable.

• More long-term nuclear PPA announcements — CEG added 920 MW in Q2 2026 with an average contract length of ~18.5 years.
• Crane Clean Energy Center restart progress, including FERC, NRC, and construction milestones.
• Q3 2026 earnings in late October/early November, testing progress toward the $11.50-$12.50 EPS guidance.
• Closing of the Brazos Valley divestiture for $860 million and use of proceeds to pay down debt.
• Future PJM capacity auction results and license extension decisions for New York nuclear units.

• Calpine integration and leverage: long-term debt is ~$19.1B and TTM FCF is only ~$0.3B, leaving limited cushion if integration stumbles.
• Crane restart execution risk: cost overruns, regulatory delays, or operational issues would hit earnings and credibility.
• Merchant power and capacity-price reversal: PJM capacity prices and power prices can normalize lower, pressuring a capital-intensive fleet.
• Policy/tax-credit risk: changes to nuclear PTCs or NRC licensing timelines would weaken the bull case.
• Valuation/multiple risk: with P/S near 3.2x and a 0.6% dividend yield, the stock relies on growth; any disappointment invites sharp de-rating.

CEG owns the scarce asset — the largest US nuclear fleet — at a time when the market wants 24/7 carbon-free power, and management is executing on that with a Q2 beat, higher guidance, and more PPAs. But as of 2026-08-27, the stock is not a clear buy: reported financials are distorted by Calpine, free cash flow is weak, debt is high, and the valuation still assumes meaningful future execution. I would wait for a lower entry closer to the $250s or for evidence of improved cash conversion before putting new money to work.

Fair value is calculated by applying a 22.5x multiple to the $12.00 midpoint of FY2026 adjusted EPS guidance. That multiple is about a 25% discount to the stock's 3-year average P/E of ~29.9, justified by weak free cash flow, $19.1B of long-term debt, merchant power cyclicality, and Calpine integration risk; successful execution could support a higher multiple, but 270 is the conservative intrinsic estimate as of 2026-08-27.